HPV triage of patients with ASCUS cervical Pap smears

Sexuality, Reproduction and Menopause

Volumn 2, Issue 3, 2004, Pages 146-153

  Kirby, Tyler O ^a   Huh, Warner K ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CLINICAL TRIAL; COLPOSCOPY; CONDYLOMA; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; EMERGENCY HEALTH SERVICE; FEMALE; FOLLOW UP; HEALTH CARE COST; HIGH RISK PATIENT; HUMAN; INFECTION RISK; LABORATORY DIAGNOSIS; META ANALYSIS; PAPANICOLAOU TEST; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RELIABILITY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEXUAL TRANSMISSION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA; VIRUS CARCINOGENESIS; WART VIRUS;

EID: 13244296821     PISSN: 15462501     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sram.2004.07.009     Document Type: Review

References (22)

1. N. Kiviat L. Koutsky J. Paavonen Cervical neoplasia and other STD-related genital tract neoplasias In: K. Holmes P. Mardh P. Sparling eds. Sexually transmitted diseases 3rd ed 1999 McGraw-Hill New York 811-832
2. W.K. Kinney M.M. Manos L.B. Hurley J.E. Ransley Where's the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses. Obstet Gynecol 91 1998 973-976
3. M.T. Fahey L. Irwig P. Macaskill Meta-analysis of Pap test accuracy Am J Epidemiol 141 1995 680-689
4. S.L. Kulasingam J.P. Hughes N.B Kiviat et al. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral JAMA 288 2002 1749-1757
5. D.T. Janerich O. Hadjimichael P.E Schwartz et al. The screening histories of women with invasive cervical cancer, Connecticut Am J Pub Health 85 1995 791-794
6. O.B. Olaniyan Validity of colposcopy in the diagnosis of early cervical neoplasia - a review Afr J Reprod Health 6 2002 59-69
7. M. Campion Preinvasive Disease In: J.S. Berek N.F. Hacker eds. Practical gynecologic oncology 3rd ed 2000 Lippincott Williams & Wilkins Philadelphia 271-344
8. L.A. Koutsky K.K. Holmes C.W Critchlow et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection N Engl J Med 327 1992 1272-1278
9. A. Hildesheim M.H. Schiffman P.E Gravitt et al. Persistence of type-specific human papillomavirus infection among cytologically normal women J Infect Dis 169 1994 235-240
10. Prevention of genital HPV infection and sequelae. Report of an external consultants' meeting. Division of STD Prevention: Department of Health and Human Services, Atlanta: Centers for Disease Control and Prevention, 1999.
11. L. Koutsky Epidemiology of genital human papillomavirus infection Am J Med 102 1997 3-8
12. S.J. Goldie L. Kuhn L. Denny A. Pollack T.C. Wright Policy analysis of cervical cancer screening strategies in low-resource settings: Clinical benefits and cost-effectiveness JAMA 285 2001 3107-3115
13. W. Cates Jr Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel Sex Transm Dis 26 4 Suppl 1999 S2-7
14. C.L. Peyton P.E. Gravitt W.C Hunt et al. Determinants of genital human papillomavirus detection in a US population J Infect Dis 183 2001 1554-1564
15. G.Y. Ho R. Bierman L. Beardsley C.J. Chang R.D. Burk Natural history of cervicovaginal papillomavirus infection in young women N Engl J Med 338 1998 423-428
16. P. Holowaty A.B. Miller T. Rohan T. To Natural history of dysplasia of the uterine cervix J Natl Cancer Inst 91 1999 252-258
17. K. Syrjanen V. Kataja M. Yliskoski F. Chang S. Syrjanen S. Saarikoski Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda System Obstet Gynecol 79 1992 675-682
18. D. Saslow C.D. Runowicz D Solomon et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer CA Cancer J Clin 52 2002 342-362
19. D. Solomon M. Schiffman R. Tarone Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial J Natl Cancer Inst 93 2001 293-299
20. l. M.M. Manos W.K. Kinney L.B Hurley et al. Identifying women with cervical neoplasia: Using human papillomavirus DNA testing for equivocal Papanicolaou results JAMA 1999 281/sb:vOlume-nr1605-10
21. A.R. Giuliano M. Papenfuss M Abrahamsen et al. Human papillomavirus infection at the United States-Mexico border: Implications for cervical cancer prevention and control Cancer Epidemiol Biomarkers Prev 10 2001 1129-1136
22. T.C. Wright ?? Jr M. Schiffman D Solomon et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening Obstet Gynecol 103 2004 304-309